# Apitoria Pharma Private Limited – FDA Inspection, Feb 9, 2019

Source: https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/20409a75-84a1-4092-aed4-c80b1ba09449
Source feed: FDA_Inspections

> FDA inspection 1082414 of Apitoria Pharma Private Limited, February 09, 2019. Classification: Official Action Indicated (OAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082414
- Company Name: Apitoria Pharma Private Limited
- Inspection Date: 2019-02-09
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1342322 - 2026-09-11
- FDA Inspection 1178447 - 2022-08-02
- FDA Inspection 1005706 - 2017-02-21
- FDA Inspection 927750 - 2015-04-30
- FDA Inspection 790022 - 2012-06-08

## Related Officers

- Issuing Officer
- [Dipesh K. Shah](https://www.keypedia.com/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)
- [FDA Associated Person](https://www.keypedia.com/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)

Company: https://www.keypedia.com/companies/apitoria-pharma-private-limited/c56154eb-1a77-4f64-9db0-4ae380d6b65e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
